Seeking Alpha

Oppenheimer recommends Express Scripts (ESRX) shares even if regulators shoot down the planned...

Oppenheimer recommends Express Scripts (ESRX) shares even if regulators shoot down the planned acquisition of Medco (MHS). Already a valuation opportunity, if the buyout fails, Medco would be badly weakened after client losses and months of limbo. If the deal closes, ESRX would be left as the only major independent pharmacy benefits manager.
Comments (1)
  • Drew Robertson
    , contributor
    Comments (309) | Send Message
     
    Sounds like what AT&T is going to do to T-Mobile.
    4 Oct 2011, 12:01 PM Reply Like
DJIA (DIA) S&P 500 (SPY)